Immune checkpoint blockade is more effective in a syngeneic mouse model of melanoma deficient in Chd1 and Map3k7 and is associated with elevated intra-tumoral CD8<sup>+</sup> T cell numbers and activation. This evidence concerns the gene CD8A and melanoma.